S1PR1 and inflammatory bowel disease: Modulation of S1PR1 has established a new approach in the treatment of autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), lupus, and psoriasis (Gonzalez-Cabrera et al., 2014; Dash et al., 2018).